Subscription and demo access


 
About Interfax
Press Releases
Products & Services
Contact us
Customer Login
 


Headlines
 

12/07 19:08   Syrian authorities already control 50 neighborhoods in east Aleppo - 70% of territory previously held by militants
 
12/07 19:08   Lithuanian citizen sentenced to 9.5 years in prison in Pskov for trying to sell 23 kilos of drugs
 
12/07 19:06   Daily Headline News for December 7, 2016
 
12/07 19:03   SIXTY-SIX MILITANTS GIVE UP WEAPONS IN ALEPPO ON WEDNESDAY - RUSSIAN RECONCILIATION CENTER
 
12/07 19:03   Uzbek president-elect declares 2017 Year of Dialogue with People
 
12/07 19:02   SYRIAN AUTHORITIES CONTROL 50 NEIGHBORHOODS IN EASTERN ALEPPO - 70% OF TERRITORY PREVIOUSLY CONTROLLED BY MILITANTS - RUSSIAN RECONCILIATION CENTER
 
12/07 19:00   Israeli ambassador Heifetz ends stint in Moscow, to represent country in Beijing from January - diplomatic mission
 
12/07 18:58   Contact group orders preparations for release of maximal number of prisoners in Donbas before New Year holidays - Kyiv
 
12/07 18:57   Next meeting of Contact Group in Minsk scheduled for Dec 21
 
12/07 18:57   Moldovan president-elect to seek resignation of prosecutor general to be appointed by outgoing president
 


 

Interfax.com  |  Interfax news  |  Pharmstandard, Millhouse close deal to acquire...


News headlines


July 25, 2014 09:25

Pharmstandard, Millhouse close deal to acquire stakes in Biocad Holding

MOSCOW. July 25 (Interfax) - Pharmstandard (MOEX: PHST), a major Russian drug maker, and Millhouse have completed individual acquisitions of shares in Biocad Holding Ltd., the principal shareholder of St. Petersburg-based biotech company CJSC Biocad, the companies said in a joint statement.

Pharmstandard acquired a 20% stake in Biocad Holding Ltd., while a company affiliated with Millhouse acquired 50%.

Pharmstandard financed the acquisition with its own money, the press release states.

Biocad CEO and founder Dmitry Morozov will retain a 30% stake in Biocad Holding Ltd and will continue to run the company with his management team, the statement said.

Biocad develops, manufactures and promotes its own and generic drugs to treat illnesses in the areas of urology, gynecology, dermatovenereology, oncology and hematology, as well as autoimmune and infectious diseases. The company has a line of 14 drugs.

"Millhouse and Pharmstandard have a successful track record of working together to develop leaders in the pharmaceutical market. The companies previously cooperated on the acquisitions of ICN Pharmaceuticals, Inc. and CJSC Masterlek, and on Pharmstandard's initial public offering," the press release said.

It was reported earlier that in this deal the companies would buy the stake of Gazprombank (MOEX: GZPR), which acquired a controlling stake in the pharmaceutical company in 2011 for about $250 million-$300 million, as well as part of the stake held by company management.

RMG senior analyst Ksenia Arutyunova valued all of Biocad at $1 billion. Therefore, the stakes acquired by Pharmstandard and Millhouse are worth $200 million and $500 million respectively.

Millhouse is acting as a financial investor, who will divest the stake at some point, Arutyunova said, adding that this stake could be bought by Pharmstandard.

Biocad currently sells its products in Russia and other CIS countries. The company has offices in Ukraine, Belarus, Brazil, China, India and the United States. Biocad is also setting up production of drugs based on monoclonal antibodies in Brazil.

Biocad has two factories in Russia - in the Moscow Region and in the St. Petersburg special economic zone. The company had revenue of 3 billion rubles in 2013.

It was reported earlier that U.S. drug makers Pfizer and Amgen were interested in buying Biocad. The company was valued at $0.75 billion-$1 billion.

Vp of

(Our editorial staff can be reached at eng.editors@interfax.ru)

/Interfax/
 Subscription
You can access a demo version of, receive more information about or subscribe to Interfax publications by filling in and returning the form below. We also have dozens of reports in the Russian language, please indicate if you are interested.
Title:


Phone:


E-mail:


First name:


Company:


Country:
Last name:


Division:


City:
Products:
Central Asia & Caucasus Business Weekly
Central Asia General Newswire
Global Gas Analytics
Global Natural Gas Daily
Interfax Via Bloomberg Terminal
Kazakhstan General Newswire
Kazakhstan Mining Weekly
Kazakhstan Oil & Gas Weekly
Russia & CIS Announcements
Russia & CIS Banking and Finance Weekly
Russia & CIS Business and Financial Daily
Russia & CIS Business and Financial Newswire
Russia & CIS Business and Investment Weekly
Russia & CIS Business Law Weekly
Russia & CIS Business news
Russia & CIS Defense Industry Weekly
Russia & CIS Diplomatic Panorama
Russia & CIS Energy Daily
Russia & CIS Energy Newswire
Russia & CIS Events Calendar
Russia & CIS Food and Agriculture Weekly
Russia & CIS General Newswire
Russia & CIS Headline News
Russia & CIS Insurance Weekly
Russia & CIS IT and Telecom Weekly
Russia & CIS Metals and Mining Weekly
Russia & CIS Military Daily
Russia & CIS Military Newswire
Russia & CIS Military Weekly
Russia & CIS Oil and Gas Weekly
Russia & CIS Presidential Bulletin
Russia & CIS Statistics Weekly
Russia Health & Pharmaceuticals
Russia Market Roundup
Russia Press Review
Ukraine Business Daily
Ukraine Business Weekly
Ukraine General Newswire
Please enter the digits from picture in the box below:

December 07, 2016
 
19:02
SYRIAN AUTHORITIES CONTROL 50 NEIGHBORHOODS IN EASTERN ALEPPO - 70% OF TERRITORY PREVIOUSLY CONTROLLED BY MILITANTS - RUSSIAN RECONCILIATION CENTER
 
19:00
Israeli ambassador Heifetz ends stint in Moscow, to represent country in Beijing from January - diplomatic mission
 
18:58
Contact group orders preparations for release of maximal number of prisoners in Donbas before New Year holidays - Kyiv
 
18:57
Next meeting of Contact Group in Minsk scheduled for Dec 21
 
18:57
Moldovan president-elect to seek resignation of prosecutor general to be appointed by outgoing president
 
18:54
 
18:54
Ukrainian army shelling cuts electricity supply at Donetsk water filtering station, water supply disrupted - DPR
 
18:53
Higher oil prices in 2017 could bring in an additional 1 trln rubles, part to go toward spending - Siluanov
 
18:52
Gorbachev calls Belavezha Accords participants led by then-leadership of Russia culprits of USSR break-up
 
18:52
Russian Eurobonds up moderately on gains for UST
 
18:47
Gorbachev confident conditions exist for development of good-neighborly relations with Japan, 'but not at the expense of trade in territories'
 
18:46
Lukoil shareholders accept 9M dividend of 75 rubles a share
 
18:46
Kazakh parliament votes for fingerprinting all citizens aged 16 and over, foreigners seeking visas
 
18:44
Kyiv continues to disregard all instructions from Contact Group, 'Normandy format' foreign ministers - Donetsk
 
 more headlines 



Interviews
 

.
Head of the delegation of the International Committee of the Red Cross (ICRC) in Russia, Belarus and Moldova Magne Barth has explained the position of the ICRC on interaction with Russian military in Syria. Earlier the Russian Defense Ministry called the ICRC reaction regarding the death of two Russian medical workers in a strike on a Russian military hospital in Syria’s Aleppo cynical.

more
.
.
President of the International Committee of the Red Cross Peter Maurer has given an interview to Interfax correspondent Alexander Korzun ahead of his visit to Russia on November 23-25, in which he speaks about topics he would discuss with Russian officials, his assessment of ICRC interaction with Russia, and problems that the organization faces in Syria and Ukraine.

more
.
.
Palestinian National Authority head Mahmoud Abbas has given an interview to Interfax ahead of a visit of Russian Prime Minister Dmitry Medvedev to Palestine, in which he speaks about Moscow‘s effort to organize Palestine-Israeli negotiations and prospects of an international conference on the Middle East settlement and expressed hope that Russian President Vladimir Putin will in the near future visit Palestine.

more

 
  
 ©   1991—2016   Interfax Information Service. All rights reserved.
contact information   |   Interfax offices   |   made by web.finmarket

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.

Browse other Interfax sites:  Interfax.ru   |   IFX.RU   |   Interfax Group   Rambler's Top100